Clonazepam for pain due to muscle spasm in a patient with vertebral compression fractures caused by multiple myeloma: a case report.

Clonazepam Facet joint pain Multiple myeloma Muscle spasm

Journal

JA clinical reports
ISSN: 2363-9024
Titre abrégé: JA Clin Rep
Pays: Germany
ID NLM: 101682121

Informations de publication

Date de publication:
09 Oct 2021
Historique:
received: 08 07 2021
accepted: 28 09 2021
revised: 01 09 2021
entrez: 9 10 2021
pubmed: 10 10 2021
medline: 10 10 2021
Statut: epublish

Résumé

Vertebral compression fractures can cause severe back pain. Although many types of analgesics and interventional treatments are available, they are sometimes ineffective in mitigating the pain. We encountered a case where clonazepam was effective for the management of severe low back pain caused by lumbar vertebral compression fractures. A 44-year-old male was diagnosed with multiple myeloma and had vertebral compression fractures of the first and second lumbar vertebrae. He had been suffering from severe low back pain on movement with muscle spasm and pain-associated anxiety. We considered this breakthrough low back pain to be caused by facet joint pain; thus, we prescribed clonazepam as a muscle relaxant and anxiolytic. Following this treatment, the intractable breakthrough pain was dramatically relieved. Clonazepam, which has both muscle relaxant and anxiolytic effects, might be helpful in mitigating pain, associated anxiety, and muscle spasms due to vertebral compression fractures.

Sections du résumé

BACKGROUND BACKGROUND
Vertebral compression fractures can cause severe back pain. Although many types of analgesics and interventional treatments are available, they are sometimes ineffective in mitigating the pain. We encountered a case where clonazepam was effective for the management of severe low back pain caused by lumbar vertebral compression fractures.
CASE PRESENTATION METHODS
A 44-year-old male was diagnosed with multiple myeloma and had vertebral compression fractures of the first and second lumbar vertebrae. He had been suffering from severe low back pain on movement with muscle spasm and pain-associated anxiety. We considered this breakthrough low back pain to be caused by facet joint pain; thus, we prescribed clonazepam as a muscle relaxant and anxiolytic. Following this treatment, the intractable breakthrough pain was dramatically relieved.
CONCLUSION CONCLUSIONS
Clonazepam, which has both muscle relaxant and anxiolytic effects, might be helpful in mitigating pain, associated anxiety, and muscle spasms due to vertebral compression fractures.

Identifiants

pubmed: 34626259
doi: 10.1186/s40981-021-00477-1
pii: 10.1186/s40981-021-00477-1
pmc: PMC8502180
doi:

Types de publication

Journal Article

Langues

eng

Pagination

75

Informations de copyright

© 2021. The Author(s).

Références

Rev Pain. 2008 Sep;2(1):8-13
pubmed: 26525677
Spine (Phila Pa 1976). 2002 Feb 1;27(3):E56-63
pubmed: 11805709
Pain Med. 2010 Nov;11(11):1674-7
pubmed: 21029349
J Pain Symptom Manage. 2003 Dec;26(6):1073-4
pubmed: 14654258
Blood Cancer J. 2019 Feb 26;9(3):27
pubmed: 30808868
Spine J. 2012 Nov;12(11):998-1005
pubmed: 23026068
Br J Haematol. 2011 Jul;154(1):76-103
pubmed: 21517805
Cochrane Database Syst Rev. 2012 May 16;(5):CD009486
pubmed: 22592742
Spine (Phila Pa 1976). 1995 Dec 15;20(24):2652-8
pubmed: 8747243
Lancet. 2009 Mar 21;373(9668):1016-24
pubmed: 19246088
Insights Imaging. 2018 Oct;9(5):773-789
pubmed: 30090998
Lancet Oncol. 2011 Mar;12(3):225-35
pubmed: 21333599
J Pain Symptom Manage. 2004 Jul;28(1):72-95
pubmed: 15223086
Laryngoscope. 2012 Apr;122(4):813-6
pubmed: 22344742
Skeletal Radiol. 2014 Jan;43(1):13-8
pubmed: 24100705
Bone. 1995 Nov;17(5 Suppl):505S-511S
pubmed: 8573428
Semin Hematol. 2001 Jul;38(3):276-85
pubmed: 11486316
Anesthesiology. 2007 Mar;106(3):591-614
pubmed: 17325518

Auteurs

Kazuki Akita (K)

Department of Anesthesiology, University of Yamanashi, 1110 Shimokato, Chuo City, Yamanashi, Japan. kakita@yamanashi.ac.jp.

Yasutomo Kumakura (Y)

Department of Anesthesiology, University of Yamanashi, 1110 Shimokato, Chuo City, Yamanashi, Japan.
Center of Medical team, University of Yamanashi Hospital, 1110 Shimokato, Chuo City, Yamanashi, Japan.

Emi Nakajima (E)

Department of Anesthesiology, University of Yamanashi, 1110 Shimokato, Chuo City, Yamanashi, Japan.
Center of Medical team, University of Yamanashi Hospital, 1110 Shimokato, Chuo City, Yamanashi, Japan.

Hiroki Ishiguro (H)

Department of Neuropsychiatry and Clinical Ethics, University of Yamanashi, 1110 Shimokato, Chuo City, Yamanashi, Japan.

Tetsuya Iijima (T)

Department of Anesthesiology, University of Yamanashi, 1110 Shimokato, Chuo City, Yamanashi, Japan.

Classifications MeSH